SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012633
Filing Date
2023-08-01
Accepted
2023-08-01 07:37:29
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20230630x10q.htm   iXBRL 10-Q 2091179
2 EX-10.1 qure-20230630xex10d1.htm EX-10.1 81545
3 EX-10.2 qure-20230630xex10d2.htm EX-10.2 446019
4 EX-31.1 qure-20230630xex31d1.htm EX-31.1 15051
5 EX-31.2 qure-20230630xex31d2.htm EX-31.2 15060
6 EX-32.1 qure-20230630xex32d1.htm EX-32.1 14743
  Complete submission text file 0001558370-23-012633.txt   8014431

Data Files

Seq Description Document Type Size
7 EX-101.SCH qure-20230630.xsd EX-101.SCH 42583
8 EX-101.CAL qure-20230630_cal.xml EX-101.CAL 48648
9 EX-101.DEF qure-20230630_def.xml EX-101.DEF 228528
10 EX-101.LAB qure-20230630_lab.xml EX-101.LAB 427513
11 EX-101.PRE qure-20230630_pre.xml EX-101.PRE 329559
56 EXTRACTED XBRL INSTANCE DOCUMENT qure-20230630x10q_htm.xml XML 1187391
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 231129673
SIC: 2834 Pharmaceutical Preparations